title: The future of induction chemotherapy for head and neck squamous cell carcinoma.
authors.forename: Missak
authors.initials: M
authors.lastname: Haigentz
authors.forename: Ezra E W
authors.initials: EE
authors.lastname: Cohen
authors.forename: Gregory T
authors.initials: GT
authors.lastname: Wolf
authors.forename: Primož
authors.initials: P
authors.lastname: Strojan
authors.forename: Avraham
authors.initials: A
authors.lastname: Eisbruch
authors.forename: Alfio
authors.initials: A
authors.lastname: Ferlito
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy; D017326:Clinical Trials, Phase III as Topic; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D060828:Induction Chemotherapy / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents